https://www.omantechnologyreporter.com/article/908314575-flower-turbines-announces-special-distributed-energy-packages-for-gulf-states Oman Technology Reporter en PressRelease 2026-04-27T05:00:00+00:00 Flower Turbines Announces Special Distributed Energy Packages for Gulf States https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/740474-5-colorful-turbines-in-harbor-4000x2548.jpeg https://www.omantechnologyreporter.com/article/908434497-clearmind-medicine-announces-evaluation-of-its-psychedelic-based-treatment-meai-for-potential-fda-breakthrough-therapy-designation Oman Technology Reporter en PressRelease 2026-04-27T11:41:00+00:00 Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.omantechnologyreporter.com/article/908434376-tovecimig-demonstrates-statistically-significant-benefit-in-companion-002-randomized-phase-2-3-study-in-patients-with-biliary-tract-cancer Oman Technology Reporter en PressRelease 2026-04-27T11:30:00+00:00 Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.omantechnologyreporter.com/article/908434384-medicus-pharma-ceo-meets-with-lawmakers-on-energy-commerce-committee-on-capitol-hill Oman Technology Reporter en PressRelease 2026-04-27T11:30:00+00:00 Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.omantechnologyreporter.com/article/908434404-hcw-biologics-delivers-a-major-update-for-its-t-cell-engager-program-revealing-mechanism-of-action-and-validating-tissue-factor-as-target-for Oman Technology Reporter en PressRelease 2026-04-27T11:30:00+00:00 HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.omantechnologyreporter.com/article/908434422-nervgen-pharma-strengthens-leadership-team-with-appointment-of-keith-vendola-as-chief-financial-officer Oman Technology Reporter en PressRelease 2026-04-27T11:30:00+00:00 NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png https://www.omantechnologyreporter.com/article/908434429-cormedix-therapeutics-announces-positive-topline-results-from-phase-iii-respect-trial-assessing-rezzayo-for-the-prophylaxis-of-invasive-fungal Oman Technology Reporter en PressRelease 2026-04-27T11:30:00+00:00 CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg https://www.omantechnologyreporter.com/article/908434491-alterity-therapeutics-receives-positive-fda-feedback-following-second-type-c-meeting-on-ath434-phase-3-program-in-multiple-system-atrophy Oman Technology Reporter en PressRelease 2026-04-27T11:25:00+00:00 Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.omantechnologyreporter.com/article/908430292-sagimet-biosciences-announces-pricing-of-175-0-million-underwritten-offering-of-series-a-common-stock Oman Technology Reporter en PressRelease 2026-04-27T11:15:04+00:00 Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.omantechnologyreporter.com/article/908429872-allot-to-release-first-quarter-2026-results-and-host-conference-call-on-may-12-2026 Oman Technology Reporter en PressRelease 2026-04-27T11:06:51+00:00 Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026 https://ml-eu.globenewswire.com/media/de6a7a3a-fc53-4a4e-9772-6201603d4770/small/allot-logo-no-tag-jpg.jpg https://www.omantechnologyreporter.com/article/908429876-aeluma-appoints-willy-rachmady-vice-president-of-strategic-partnerships-and-ecosystem Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem https://ml.globenewswire.com/media/b1015780-d7ba-46d1-b327-269ba03ba2ab/small/almu-logo-jpg.jpg https://www.omantechnologyreporter.com/article/908429883-fulcrum-therapeutics-announces-recent-business-highlights-and-financial-results-for-first-quarter-2026 Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.omantechnologyreporter.com/article/908429887-recognized-for-best-use-of-tech-in-hr-vetty-wins-bronze-stevie-in-2026-american-business-awards Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Recognized for Best Use of Tech in HR, Vetty Wins Bronze Stevie® in 2026 American Business Awards® https://ml.globenewswire.com/media/21066ed2-0106-4e28-a0e5-427d9228a3d1/small/vetty-logo-2022-png.png https://www.omantechnologyreporter.com/article/908429911-palomino-laboratories-inc-closes-15-million-at-4-share Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Palomino Laboratories Inc. Closes $15 Million at $4/share https://ml.globenewswire.com/media/3aaf8e51-09af-4413-8132-02b7b76f4c76/small/pl-tm-white-and-gold-on-blue-jpg.jpg https://www.omantechnologyreporter.com/article/908429920-sionna-therapeutics-completes-enrollment-in-precision-cf-phase-2a-trial-evaluating-nbd1-stabilizer-sion-719-added-to-standard-of-care-in Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.omantechnologyreporter.com/article/908430027-secura-bio-announces-journal-of-clinical-oncology-publication-of-final-results-of-duvelisib-primo-phase-2-trial-in-relapsed-refractory-peripheral Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma https://ml.globenewswire.com/media/0c6ab6dc-8076-44dc-acba-60a586a93721/small/securabio-brand-rgb-logo-fullcolor-png.png https://www.omantechnologyreporter.com/article/908430111-oruka-therapeutics-announces-positive-week-16-data-for-orka-001-from-the-ongoing-everlast-a-phase-2a-trial-in-moderate-to-severe-plaque-psoriasis Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.omantechnologyreporter.com/article/908430156-intellia-therapeutics-reports-positive-phase-3-results-in-hereditary-angioedema-marking-a-global-first-for-in-vivo-gene-editing Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.omantechnologyreporter.com/article/908430163-intellia-therapeutics-initiates-rolling-submission-of-biologics-license-application-to-fda-for-lonvoguran-ziclumeran-lonvo-z-as-a-one-time-treatment Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.omantechnologyreporter.com/article/908430186-harrow-to-report-first-quarter-2026-financial-results-after-market-close-on-may-11-2026 Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 https://ml.globenewswire.com/media/8e0382bf-e00a-4591-87aa-4e90001aabea/small/bw-harrow-logo-cmyk-wtag-wr-jpg.jpg https://www.omantechnologyreporter.com/article/908430187-altimmune-announces-closing-of-225-million-oversubscribed-public-offering-of-securities Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.omantechnologyreporter.com/article/908430189-cardiff-oncology-to-host-key-opinion-leader-discussion-on-onvansertib-s-promising-single-agent-activity Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.omantechnologyreporter.com/article/908430195-sagimet-biosciences-provides-strategic-and-corporate-updates Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Sagimet Biosciences Provides Strategic and Corporate Updates https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.omantechnologyreporter.com/article/908430198-ocular-therapeutix-to-participate-in-may-scientific-and-investor-conferences Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.omantechnologyreporter.com/article/908430200-seer-board-of-directors-unanimously-rejects-revised-unsolicited-proposal-from-radoff-jec-group Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.omantechnologyreporter.com/article/908430206-ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligand-s-position-as-a-leading-biopharma-royalty-aggregator Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator https://ml.globenewswire.com/media/46cbb269-1ae4-4441-a46a-d782ffb436dc/small/xoma-royalty-2c-png.png https://www.omantechnologyreporter.com/article/908430207-ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligand-s-position-as-a-leading-biopharma-royalty-aggregator Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator  https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.omantechnologyreporter.com/article/908430211-moonfox-alternative-data-redefines-china-insights-at-neudata-hong-kong-summit-a-triple-threat-of-online-offline-and-transactional-data Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 MoonFox Alternative Data Redefines China Insights at Neudata Hong Kong Summit: A Triple-Threat of Online, Offline, and Transactional Data https://ml.globenewswire.com/media/36c8f943-f1d6-4fc9-ae7e-52270f6b5096/medium/joken-liu-presented-at-neudata.jpg https://www.omantechnologyreporter.com/article/908430252-youxin-technology-announces-to-strategically-acquire-yatop-worth-10-8-million-shares-to-expand-global-tiktok-ecosystem-and-digital-commerce Oman Technology Reporter en PressRelease 2026-04-27T11:00:00+00:00 Youxin Technology Announces to Strategically Acquire YATOP Worth $10.8 Million Shares to Expand Global TikTok Ecosystem and Digital Commerce Capabilities https://ml.globenewswire.com/media/b427409e-182c-4359-98f9-0cbc3cf76525/small/logo-jpg.jpg https://www.omantechnologyreporter.com/article/908425638-fulcrum-therapeutics-appoints-josh-lehrer-to-its-board-of-directors Oman Technology Reporter en PressRelease 2026-04-27T10:55:00+00:00 Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.omantechnologyreporter.com/article/908425640-eton-pharmaceuticals-announces-initiation-of-clinical-study-for-product-candidate-et-700 Oman Technology Reporter en PressRelease 2026-04-27T10:50:00+00:00 Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.omantechnologyreporter.com/article/908418157-owlting-group-nasdaq-owls-to-announce-full-year-2025-financial-results Oman Technology Reporter en PressRelease 2026-04-27T10:03:00+00:00 OwlTing Group (NASDAQ: OWLS) to Announce Full Year 2025 Financial Results https://ml.globenewswire.com/media/f044d335-9e0f-4fe4-8ffd-3414828e326f/small/owlting-logo-primary-png.png https://www.omantechnologyreporter.com/article/908418144-relay-therapeutics-announces-clinical-data-for-zovegalisib-plus-atirmociclib-triplet-combination-supportive-of-further-development-in-frontline Oman Technology Reporter en PressRelease 2026-04-27T10:00:00+00:00 Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.omantechnologyreporter.com/article/908401914-ataibeckley-and-psypan-receive-a-silver-award-in-2026-patient-participant-index-reflecting-ongoing-commitment-to-participant-informed-research Oman Technology Reporter en PressRelease 2026-04-27T08:05:00+00:00 AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.omantechnologyreporter.com/article/908401976-simply-contact-launches-ai-call-simulation-onboarding-program-for-multilingual-contact-center-agents Oman Technology Reporter en PressRelease 2026-04-27T08:04:43+00:00 Simply Contact Launches AI Call Simulation Onboarding Program for Multilingual Contact Center Agents https://ml.globenewswire.com/media/b955e110-ba76-4073-8ad3-5e9b85ac861f/medium/simply-contact-launches-ai-call-simulation-onboarding-progra.jpg https://www.omantechnologyreporter.com/article/908395646-full-year-results-for-the-year-ended-31-december-2025 Oman Technology Reporter en PressRelease 2026-04-27T07:23:29+00:00 Full Year Results for the year ended 31 December 2025 https://ml.globenewswire.com/media/c4b6af1c-c16f-4ab6-81f1-2cec4970ea26/small/bango-master-logo-hires-png.png https://www.omantechnologyreporter.com/article/908392269-veson-and-veracity-by-dnv-partner-to-streamline-verified-emissions-reporting-and-commercial-voyage-management Oman Technology Reporter en PressRelease 2026-04-27T07:00:00+00:00 Veson and Veracity by DNV partner to streamline verified emissions reporting and commercial voyage management https://ml.globenewswire.com/media/6f117f11-95c0-45f2-8699-98a2ced03b1a/medium/veson-nautical.jpg https://www.omantechnologyreporter.com/article/908381127-ose-immunotherapeutics-welcomes-fda-orphan-drug-designation-granted-to-pegrizeprument-vel-101-for-prevention-of-organ-rejection-in-heart-transplant Oman Technology Reporter en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://www.omantechnologyreporter.com/article/908381134-ose-immunotherapeutics-se-f-licite-de-l-octroi-de-la-d-signation-de-m-dicament-orphelin-par-la-fda-du-pegrizeprument-vel-101-pour-la-pr-vention-du Oman Technology Reporter en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics se félicite de l'octroi de la désignation de médicament orphelin par la FDA du pegrizeprument (VEL-101) pour la prévention du rejet d’organe dans la transplantation cardiaque https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://www.omantechnologyreporter.com/article/908378484-santhera-erh-lt-positive-stellungnahme-des-chmp-zur-ausweitung-der-anwendung-von-agamree-vamorolon-bei-p-diatrischen-dmd-patienten-ab-zwei-jahren Oman Technology Reporter en PressRelease 2026-04-27T05:00:00+00:00 Santhera erhält positive Stellungnahme des CHMP zur Ausweitung der Anwendung von AGAMREE® (Vamorolon) bei pädiatrischen DMD-Patienten ab zwei Jahren in der EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.omantechnologyreporter.com/article/908378495-santhera-receives-positive-chmp-opinion-to-expand-agamree-vamorolone-use-in-pediatric-dmd-patients-aged-two-and-older-in-the-eu Oman Technology Reporter en PressRelease 2026-04-27T05:00:00+00:00 Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.omantechnologyreporter.com/article/908371330-vcitychain-dpos-mainnet-officially-launches-building-a-high-performance-autonomous-public-blockchain-for-a-new-web4-infrastructure-ecosystem Oman Technology Reporter en PressRelease 2026-04-27T04:00:00+00:00 Vcitychain DPoS Mainnet Officially Launches Building a High-Performance Autonomous Public Blockchain for a New Web4 Infrastructure Ecosystem https://ml.globenewswire.com/media/69b81850-755b-480c-b410-8679e67ac75d/small/screenshot-2026-04-26-093134-png.png https://www.omantechnologyreporter.com/article/908367164-dark-horse-consulting-group-and-porton-advanced-announce-memorandum-of-understanding-providing-a-streamlined-path-to-conducting-iits-in-china Oman Technology Reporter en PressRelease 2026-04-27T03:30:00+00:00 Dark Horse Consulting Group and Porton Advanced Announce Memorandum of Understanding Providing a Streamlined Path to Conducting IITs in China https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.omantechnologyreporter.com/article/908364932-here-technologies-deepens-collaboration-with-china-s-intelligent-driving-innovator-neuehct-to-accelerate-global-noa-expansion Oman Technology Reporter en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies deepens collaboration with China’s intelligent driving innovator neueHCT to accelerate global NOA expansion https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologies-deepens-collaboration-with-chinas-intellig.JPG https://www.omantechnologyreporter.com/article/908364933-here-technologies-neuehct-noa Oman Technology Reporter en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies、中国のインテリジェントドライビング分野を牽引するneueHCTとの協業を強化し、グローバルNOA展開を加速 https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologies-neuehct-noa.JPG https://www.omantechnologyreporter.com/article/908364935-here-technologies-neuehct-noa Oman Technology Reporter en PressRelease 2026-04-27T03:11:16+00:00 HERE Technologies深化与中国智能驾驶创新企业智驾新程neueHCT合作，加速NOA全球布局 https://ml-eu.globenewswire.com/media/df5dd056-7ac1-4ee2-aa19-025172aeaeb1/medium/here-technologiesneuehct-noa.JPG https://www.omantechnologyreporter.com/article/908349713-crypto-news-today-alphapepe-binance-listing-talks-accelerate-whilst-xrp-price-prediction-sets-target-at-8-00 Oman Technology Reporter en PressRelease 2026-04-27T00:30:00+00:00 Crypto News Today: AlphaPepe Binance Listing Talks Accelerate whilst XRP Price Prediction Sets Target at $8.00 https://ml.globenewswire.com/media/896bf817-3ed3-4685-a620-611e0caa8b41/medium/alphapepe.jpg https://www.omantechnologyreporter.com/article/908341796-crypto-news-alphapepe-presale-nears-1m-raise-whilst-solana-price-prediction-eyes-120 Oman Technology Reporter en PressRelease 2026-04-26T23:30:00+00:00 Crypto News: AlphaPepe Presale Nears $1M Raise whilst Solana Price Prediction Eyes $120 https://ml.globenewswire.com/media/58449edb-950c-423e-9e0b-6afe445e648d/medium/alphapepe-presale.jpg https://www.omantechnologyreporter.com/article/908282227-oruka-therapeutics-to-host-conference-call-to-report-week-16-data-for-orka-001-from-the-ongoing-everlast-a-trial-on-april-27-2026 Oman Technology Reporter en PressRelease 2026-04-26T16:00:00+00:00 Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.omantechnologyreporter.com/article/908187413-crypto-news-alphapepe-presale-crosses-960-000-raised-as-bitcoin-price-prediction-aims-at-200-000 Oman Technology Reporter en PressRelease 2026-04-26T02:00:00+00:00 Crypto News: AlphaPepe Presale Crosses $960,000 Raised as Bitcoin Price Prediction Aims at $200,000 https://ml.globenewswire.com/media/85ee43ed-6f26-415f-92df-433d205e745e/medium/alphapepe.jpg https://www.omantechnologyreporter.com/article/908174833-how-to-sell-a-business-without-a-broker-new-course-helps-owners-keep-more-of-their-money Oman Technology Reporter en PressRelease 2026-04-26T00:30:00+00:00 How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money https://pressranger.s3.us-west-1.amazonaws.com/3235787/HPJeschke1-24-23-2.png https://www.omantechnologyreporter.com/article/908162646-crypto-news-alphapepe-defi-exchange-progress-hits-1-000-demo-users-whilst-dogecoin-price-prediction-points-to-1-00 Oman Technology Reporter en PressRelease 2026-04-25T23:00:00+00:00 Crypto News: AlphaPepe DeFi Exchange Progress Hits 1,000 Demo Users whilst Dogecoin Price Prediction Points To $1.00 https://ml.globenewswire.com/media/09516d07-1b1e-451d-8188-b2d6b0d71ac3/medium/alphapepe.jpg https://www.omantechnologyreporter.com/article/908097107-study-shows-implicity-s-new-agnostic-cloud-based-ai-algorithm-further-reduces-false-alerts-even-after-manufacturer-ai-filtering-in-modern-devices Oman Technology Reporter en PressRelease 2026-04-25T15:00:00+00:00 Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices https://ml.globenewswire.com/media/d7822800-7d4d-420d-aa7f-89a50a370756/small/implicity-logo-jpg.jpg